InsiderClue
← All stocks

NEUROCRINE BIOSCIENCES INC

NBIX Mostly scheduled
CIK 0000914475 #761 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$77.87M
$2.32M on a plan · $75.51M straight out of an exercise
Sold at will
$42.59K
1 of 40 sales
Net
−$77.87M
−$42.59K against sales at will

By person

20 insiders · 42 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
GORMAN KEVIN CHARLES
Director
—
$37.82M (1) scheduled
−$37.82M
517,797
0.5094%
$81.40M
+0.6%
Cooke Julie
Chief Human Resources Officer
—
$5.77M (5) scheduled
−$5.77M
24,025
0.0236%
$3.78M
+29.3%
Gano Kyle
Chief Executive Officer
—
$4.87M (3) scheduled
−$4.87M
154,728
0.1522%
$24.32M
+14.0%
Lippoldt Darin
Chief Legal Officer
—
$4.20M (5) scheduled
−$4.20M
56,793
0.0559%
$8.93M
+42.9%
SHERWIN STEPHEN A
Director
—
$4.13M (5) scheduled
−$4.13M
14,860
0.0146%
$2.34M
−43.9%
Delaet Ingrid
Chief Regulatory Officer
—
$3.75M (5) scheduled
−$3.75M
18,289
0.0180%
$2.87M
+629.5%
Onyia Jude
Chief Scientific Officer
—
$3.47M (2) scheduled
−$3.47M
22,647
0.0223%
$3.56M
+64.9%
RASTETTER WILLIAM H
Director
—
$2.73M (1) scheduled
−$2.73M
43,678
0.0430%
$6.87M
+16.5%
POPS RICHARD F
Director
—
$2.36M (1) scheduled
−$2.36M
37,798
0.0372%
$5.94M
+19.6%
LYONS GARY A
Director
—
$2.29M (1) scheduled
−$2.29M
122,141
0.1202%
$19.20M
+2.6%
MORROW GEORGE J
Director
—
$2.15M (1) scheduled
−$2.15M
10,386
0.0102%
$1.63M
+147.3%
Norwalk Leslie V
Director
—
$1.97M (5) scheduled
−$1.97M
2,430
0.0024%
$381.99K
+144.5%
BENEVICH ERIC
Chief Commercial Officer
—
$1.24M (2) scheduled
−$1.24M
67,297
0.0662%
$10.58M
+40.0%
Boyer David W.
Chief Corp. Affairs Officer
—
$739.07K (2) scheduled
−$739.07K
8,722
0.0086%
$1.37M
+312.0%
ABERNETHY MATT
Chief Financial Officer
—
$363.28K (1) scheduled
−$363.28K
42,808
0.0421%
$6.73M
+34.1%
ROBERTS EIRY
Chief Medical Officer
—
—
—
35,640
0.0351%
$5.60M
+50.3%
Mercier Johanna
Director
—
—
—
6,853
0.0067%
$1.08M
+226.3%
POON CHRISTINE A
Director
—
—
—
4,753
0.0047%
$747.16K
—
Sharp Shalini
Director
—
—
—
4,088
0.0040%
$642.63K
+311.3%
Keswani Sanjay Chandru
Chief Medical Officer
—
—
—
3,281
0.0032%
$515.77K
—

Individual transactions

32
Insider
Date
Role
Action
Shares
Price
Amount
BENEVICH ERIC
9 Sep 2026
Chief Commercial Officer
Sold after exercise
2,154
$154.61
$333.03K
Delaet Ingrid
10 Jul 2026
Chief Regulatory Officer
Sold after exercise
4,367
$181.02
$790.51K
Delaet Ingrid
9 Jul 2026
Chief Regulatory Officer
Sold after exercise
8,433
$178.72
$1.51M
Lippoldt Darin
9 Jul 2026
Chief Legal Officer
Sold after exercise
10,000
$179.60
$1.80M
Delaet Ingrid
8 Jul 2026
Chief Regulatory Officer
Sold after exercise
2,737
$178.54
$488.67K
Delaet Ingrid
7 Jul 2026
Chief Regulatory Officer
Sold after exercise
3,401
$178.57
$607.31K
Lippoldt Darin
29 Jun 2026
Chief Legal Officer
Sold after exercise
1,690
$170.81
$288.68K
Lippoldt Darin
29 Jun 2026
Chief Legal Officer
Sold after exercise
8,110
$170.03
$1.38M
Lippoldt Darin
26 Jun 2026
Chief Legal Officer
Sold after exercise
200
$169.57
$33.91K
SHERWIN STEPHEN A
5 Jun 2026
Director
Sold after exercise
1,843
$167.31
$308.36K
SHERWIN STEPHEN A
5 Jun 2026
Director
Sold after exercise
5,829
$166.56
$970.86K
SHERWIN STEPHEN A
5 Jun 2026
Director
Sold after exercise
6,896
$165.79
$1.14M
SHERWIN STEPHEN A
5 Jun 2026
Director
Sold after exercise
2,549
$164.44
$419.16K
SHERWIN STEPHEN A
5 Jun 2026
Director
Sold after exercise
7,883
$163.81
$1.29M
Cooke Julie
2 Jun 2026
Chief Human Resources Officer
Sold after exercise
3,520
$158.59
$558.24K
Cooke Julie
2 Jun 2026
Chief Human Resources Officer
Sold after exercise
9,521
$157.62
$1.50M
Cooke Julie
2 Jun 2026
Chief Human Resources Officer
Sold after exercise
4,216
$156.77
$660.93K
Cooke Julie
2 Jun 2026
Chief Human Resources Officer
Sold after exercise
5,466
$155.46
$849.73K
Cooke Julie
2 Jun 2026
Chief Human Resources Officer
Sold after exercise
14,214
$154.83
$2.20M
Onyia Jude
1 Jun 2026
Chief Scientific Officer
Sold after exercise
11,000
$160.25
$1.76M
Delaet Ingrid
29 May 2026
Chief Regulatory Officer
Sold after exercise
2,261
$156.71
$354.32K
Onyia Jude
27 May 2026
Chief Scientific Officer
Sold after exercise
11,000
$155.53
$1.71M
GORMAN KEVIN CHARLES
19 May 2026
Director
Sold after exercise
245,088
$154.33
$37.82M
POPS RICHARD F
15 May 2026
Director
Sold after exercise
15,000
$157.65
$2.36M
Gano Kyle
16 Jan 2026
Chief Executive Officer
Sold after exercise
1,812
$132.71
$240.48K
Gano Kyle
16 Jan 2026
Chief Executive Officer
Sold after exercise
34,588
$132.70
$4.59M
Norwalk Leslie V
15 Dec 2025
Director
Sold after exercise
5,000
$152.23
$761.14K
Lippoldt Darin
8 Dec 2025
Chief Legal Officer
Sold after exercise
4,376
$159.65
$698.62K
LYONS GARY A
3 Dec 2025
Director
Sold after exercise
15,000
$152.61
$2.29M
BENEVICH ERIC
28 Nov 2025
Chief Commercial Officer
Sold after exercise
5,970
$151.74
$905.88K
MORROW GEORGE J
25 Nov 2025
Director
Sold after exercise
15,000
$143.37
$2.15M
RASTETTER WILLIAM H
5 Nov 2025
Director
Sold after exercise
18,000
$151.82
$2.73M
Show all 42 transactions →

What was left out

Form 4 filings counted 80
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 32
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 969,824
History held since 2 Sep 2016